Neogen Chemicals Ltd Q3 FY2025 Concall Summary

Source transcript PDF: https://assets.stockscans.in/docs/5f1a8fvre13fthuxwgixnm68.pdf

Key Takeaways


Battery Chemicals: The Waiting Game

Dr. Harin Kanani: "I think we will have some pain in 2025 and 2026, but I think second half of 2026-27 onwards we should be good and with the giga factories which are coming and the position in which Neogen is, we are quite confident to achieve…FY28 or FY29, the guidance which we have given for full utilisation of our electrolyte plant."

Standalone Business: The Here and Now


Margins, Costs & Operational Levers


The Localisation Moat

Dr. Harin Kanani: "Already China is doing predatory pricing, but when we look at our 30 KTA and we look at China, then we look at further logistic costs in bringing those containers, and sending them back. And then if you further factor in customs duties which are expected to come in beyond 2026. So, I think when you factor all of that in, most customers can clearly see value in a local supplier."

Lithium Price & Raw Material Dynamics

Dr. Harin Kanani: "The current price is not sustainable because majority of the new miners are not able to make money. So, if the situation doesn't change, you know, they will stop production and then you will have another supply side shock."

Capacity Build-Out & Approvals


Guidance & Commitments

CommitmentSpecificsTimeline
Standalone revenue₹950 to ₹1,000 croreFY26
Battery chemicals revenue (current year)₹20-30 crore (revised down from ₹50-75 crore)FY25
Battery chemicals revenue (next year)Upper end ₹500 crore, but "under review"FY26
International salt customer audit and approvalAudit and sample approval expected; commercial sales commence thereafterQ4 FY25 or maximum early Q1 FY26
Domestic giga-factory ramp-upRamp to closer to giga scaleEnd of Q4 FY25 or early Q1 FY26
Second giga factory startOperations beginH2 of calendar 2025
Existing salt capacity (400 MTPA) full contributionFull volume contributionQ1, maximum Q2 FY26
Salt capacity expansion to 2,500 tonnesPhased commissioningJune and September 2025
Salt capacity expansion to 5,500 tonnesFull capacity availableEnd of FY26
BuLi capacity doublingDoubling with very small CAPEX, subject to local approvalNext financial year
BuLi revenueCloser to or exceeding ₹100 croreFY26
Pakhajan commercial productionStart of commercial productionFY26
Pakhajan trial productionTrial production beginsEnd of 2026
Full electrolyte plant utilisation30 GWh capacity filledFY28 or FY29
CSM contribution to overall revenue15% to 20%Next year

Key Metrics

MetricQ3 FY25
Revenue₹201 crore, 22% growth YoY
Organic revenue₹177 crore, 36% increase YoY
Inorganic revenue₹24 crore, 29% decline YoY
EBITDA₹34.6 crore, 71% growth YoY
EBITDA margin17.2%, consolidated
Profit After Tax₹10 crore
Organic revenue impact from raw material price decline₹34 crore higher would have been recorded in Q3 FY25, adjusting for bromine and lithium price fall
Inorganic revenue impact from raw material price decline₹13 crore higher would have been recorded in Q3 FY25, adjusting for bromine and lithium price fall
FY26 standalone revenue guidance₹950 to ₹1,000 crore
Battery chemicals revenue guidance for FY25₹20 to ₹30 crore, revised from earlier expectation of ₹50 to ₹75 crore
Battery chemicals revenue YTDMore than ₹10 crore, double digits
CSM business contribution~14% of overall revenue, fluctuated between 12% to 15% during FY25
BuLi Chem EBITDA margin~18%, plus or minus 1% to 1.5%
Total CAPEX envisaged₹1,500 crore
CAPEX deployed till Q3 FY25~₹419 crore
Standalone debtClose to ₹450 crore
Lithium electrolyte salts and additives capacity at Dahej400 MTPA, expanding to 2,500 MTPA by next financial year and 5,500 MTPA by end of next financial year
Electrolyte capacity at Dahej2,000 MTPA
Greenfield battery materials facility civil work completion70%
Giga factories expected by end of 2026At least 5, with capacities between 5 GWh to 30 GWh
Active international customers for electrolyte salts4 to 5, out of more than 20 to 25 engaged globally
Battery chemicals revenue band for FY26 (Neogen Ionics)₹300 to ₹500 crore, upper end under review